A Phase 1 interventional study of RUNX1 mRNA in osteoarthritis patients
Recruiting Phase 1 ACTRN12625000800426
Study Description
A safety study testing an experimental RNA treatment (RUNX1 mRNA) given as a knee injection in patients with arthritis who need knee replacement surgery
Study Details
- Registry ID:
- ACTRN12625000800426
- Conditions:
- osteoarthritis, knee replacement
- Phase:
- Phase 1
- Target Enrollment:
- 12 participants
- Start Date:
- Age Range:
- 18–85 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
The Royal Adelaide Hospital
ADELAIDE, South Australia, Australia
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.